Tao Ye Group
School of Chemical Biology & Biotechnology

Cancer Letters paper accepted

时间:2013-07-10

Detailed studies on the design, synthesis and biological evaluation of cyclinE/cyclinA-CDK2 inhibitor targeting p27Kip1 degradation has been published by Cancer Letters 2013, 333, 103-112.